Neogen (NEOG)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$11.83+1.63%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · NEOG
Next print, the company's guidance track record, and the earnings events we've seen in the last few years.
Likelihood the company beats analyst consensus on its next print. Read from its own beat history plus how sector peers have been reporting. Not a price-direction call: a serial beater often has the beat already priced in.
Prints it beat consensus, recent quarters.
Indicative, not a guarantee. Base rate ~71%.
Industry peers that beat since this name last reported.
Management's most recent EPS guidance action.
expected = 0.35*own_median(-7.1) + peer(0.2*6.2) + term(0.0) → -1.25% (capped ±15.0)
in 32 days
Average absolute move on past earnings days.
Annualized: recent baseline volatility.
Of the last 0 guided quarters.
Actual vs. guided EPS, signed.
Excess return vs. sector ETF, day after print.
Earnings prints and pre-announcements detected in the SEC filing stream.
Results of Operations and Financial Condition On July 30, 2026, Neogen Corporation issued a press release announcing results of operations for its fiscal 2026 fourth quarter and full fiscal year ended May 31, 2026. A copy of the press release is attached as Exhibit 99.1 to this report. This Form 8-K and the attached exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not incorporated by reference into any filing of the Reg…
Quarterly EPS and revenue actuals vs. consensus across the last eight quarters (including beat/miss size and the forward consensus heading into the next print) are on the way.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Results of Operations and Financial Condition On April 9, 2026, Neogen Corporation issued a press release announcing results of operations for its fiscal 2026 third quarter ended February 28, 2026. A copy of the press release is attached as Exhibit 99.1 to this report. This Form 8-K and the attached exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not incorporated by reference into any filing of the Registrant, whether…
Results of Operations and Financial Condition On January 8, 2026, Neogen Corporation issued a press release announcing results of operations for its fiscal 2026 second quarter ended November 30, 2025. A copy of the press release is attached as Exhibit 99.1 to this report. This Form 8-K and the attached exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not incorporated by reference into any filing of the Registrant, wheth…
Results of Operations and Financial Condition On October 9, 2025, Neogen Corporation issued a press release announcing results of operations for its fiscal 2026 first quarter ended August 31, 2025. A copy of the press release is attached as Exhibit 99.1 to this report. This Form 8-K and the attached exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not incorporated by reference into any filing of the Registrant, whether…
Results of Operations and Financial Condition On July 29, 2025, Neogen Corporation issued a press release announcing results of operations for its fiscal 2025 fourth quarter and twelve months ended May 31, 2025. A copy of the press release is attached as Exhibit 99.1 to this report. This Form 8-K and the attached exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not incorporated by reference into any filing of the Regist…
Results of Operations and Financial Condition On April 9, 2025, Neogen Corporation issued a press release announcing preliminary results of operations for its fiscal 2025 third quarter ended February 28, 2025. A copy of the press release is attached as Exhibit 99.1 to this report. This Form 8-K and the attached exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not incorporated by reference into any filing of the Registra…
Results of Operations and Financial Condition On January 10,2025, Neogen Corporation issued a press release announcing preliminary results of operations for its fiscal 2025 second quarter ended November 30, 2024. A copy of the press release is attached as Exhibit 99.1 to this report. This Form 8-K and the attached exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not incorporated by reference into any filing of the Regis…
Results of Operations and Financial Condition On October 10, 2024, Neogen Corporation issued a press release announcing results of operations for its fiscal 2025 first quarter ended August 31, 2024. A copy of the press release is attached as Exhibit 99.1 to this report. This Form 8-K and the attached exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not incorporated by reference into any filing of the Registrant, whether…
Results of Operations and Financial Condition On July 30, 2024, Neogen Corporation issued a press release announcing results of operations for its fiscal 2024 fourth quarter and twelve months ended May 31, 2024. A copy of the press release is attached as Exhibit 99.1 to this report. This Form 8-K and the attached exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not incorporated by reference into any filing of the Regist…
Results of Operations and Financial Condition On April 9, 2024, Neogen Corporation issued a press release announcing results of operations for its fiscal 2024 third quarter ended February 29, 2024. A copy of the press release is attached as Exhibit 99.1 to this report. This Form 8-K and the attached exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not incorporated by reference into any filing of the Registrant, whether…